1 Jan 2014 Jahr - Pembrolizumab
Beschreibung:
Pembrolizumab is approved for advanced melanoma treatment by the FDA. This monoclonal antibody blocks a protein called PD1's activity on immune cells, which increases the strength of the immune response to cancer.
Zugefügt zum Band der Zeit:
Datum: